↓ Skip to main content

American Association for Cancer Research

Article Metrics

A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell–Mediated Antitumor Responses in Human B-cell Malignancies

Overview of attention for article published in Cancer Immunology Research, November 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
5 tweeters
facebook
1 Facebook page

Readers on

mendeley
10 Mendeley
Title
A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell–Mediated Antitumor Responses in Human B-cell Malignancies
Published in
Cancer Immunology Research, November 2020
DOI 10.1158/2326-6066.cir-20-0138
Pubmed ID
Authors

Iris de Weerdt, Roeland Lameris, George L. Scheffer, Jana Vree, Renate de Boer, Anita G. Stam, Rieneke van de Ven, Mark-David Levin, Steven T. Pals, Rob C. Roovers, Paul W.H.I. Parren, Tanja D. de Gruijl, Arnon P. Kater, Hans J. van der Vliet

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 40%
Other 2 20%
Student > Ph. D. Student 2 20%
Professor 1 10%
Unknown 1 10%
Readers by discipline Count As %
Immunology and Microbiology 6 60%
Business, Management and Accounting 1 10%
Biochemistry, Genetics and Molecular Biology 1 10%
Social Sciences 1 10%
Unknown 1 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 January 2021.
All research outputs
#5,250,563
of 17,036,910 outputs
Outputs from Cancer Immunology Research
#523
of 1,081 outputs
Outputs of similar age
#148,179
of 382,435 outputs
Outputs of similar age from Cancer Immunology Research
#15
of 33 outputs
Altmetric has tracked 17,036,910 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,081 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 10.0. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 382,435 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.